Recruiting Trials

MASC Trials brings together health professionals to coordinate clinical trials across our numerous melanoma and skin cancer trial sites located at hospitals and clinics throughout Australia and overseas.

The recruiting trials listed on this page are fully approved and accepting patients. Click on the trial names below for further information about trials currently accepting patients.

MASC Trials cannot enrol patients into a trial.

Learn how to participate in one of our clinical trials here.

Melanoma

Metastatic Melanoma

Uveal Melanoma

Merkel Cell Carcinoma

Squamous Cell Carcinoma

01.10 CARPETS

Phase I study of safety and immune effects of an escalating dose of autologous GD2 chimeric antigen receptor-expressing peripheral blood T cells in patients with metastatic melanoma

Chair

Professor Michael Brown

Registration ID

Trial Status

Recruiting Trial

MASC Trials Contact

10.17 GoTHAM

A Phase Ib/II study of combination avelumab with peptide receptor radionuclide therapy or conventional fractioned radiotherapy in patients with metastatic Merkel cell carcinoma

Chair

Associate Professor Shahneen Sandhu

Registration ID

Trial Status

Recruiting Trial

MASC Trials Contact

02.18 MelMarT-II

A Phase III, multi-centre, multi-national randomised control trial investigating 1cm v 2cm wide excision margins for primary cutaneous melanoma

Chair

Professor Michael Henderson and Professor Marc Moncrieff

Registration ID

Trial Status

Recruiting Trial

MASC Trials Contact

03.18 I-MAT

A randomised, placebo-controlled, Phase II trial of adjuvant Avelumab in patients with stage I-III Merkel cell carcinoma

Chair

Dr Wen Xu

Registration ID

Trial Status

Recruiting Trial

MASC Trials Contact

02.19 IMAGE

Melanoma Surveillance Photography to improve early detection of melanoma in very high risk (or high risk) patients

Chair

Associate Professor Victoria Mar

Registration ID

Trial Status

Recruiting Trial

MASC Trials Contact

07.17 Uveal Melanoma Registry

A Prospective Natural History Study in Uveal Melanoma

Chair

Professor Anthony Joshua

Registration ID

Trial Status

Recruiting Trial

MASC Trials Contact

01.21 SiroSkin

A multi-centre, randomised, double-blind, placebo-controlled trial of 1% topical Sirolimus in the chemoprevention of facial squamous cell carcinomas in solid organ transplant recipients

Chair

Professor Kiarash Khosrotehrani

Provisional Registration ID

Trial Status

Recruiting Trial

MASC Trials Contact

14.20 SOCRATES

Statins and prOgression of Coronary atheRosclerosis in melanomA patients Treated with chEckpoint inhibitorS

Chair

Professor Stephen Nicholls

Registration ID

Trial Status

Recruiting Trial

MASC Trials Contact